Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
136.7 USD | +1.55% | -2.70% | +3.76% |
May. 28 | Neurocrine Biosciences Says CEO Kevin Gorman Retiring | MT |
May. 28 | Neurocrine founder-CEO Gorman to retire in October | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.76% | 13.55B | |
+8.92% | 114B | |
+10.48% | 104B | |
-1.83% | 22.57B | |
-6.45% | 22.5B | |
-10.39% | 17.95B | |
-42.36% | 16.48B | |
-14.45% | 15.82B | |
+28.94% | 10.99B | |
+83.87% | 7.96B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Neurocrine Biosciences Swings to Q1 Adjusted Earnings as Revenue Increases -- Shares Jump Pre-Bell